Characterization of recombinant hERG K+ channel inhibition by the active metabolite of amiodarone desethyl-amiodarone
Abstract The aim of this study was to determine the effects of desethyl-amiodarone (DEA), the major metabolite of the class III antiarrhythmic drug amiodarone, on human ether-à-go-go-related gene ( hERG ) encoded potassium channel current. Materials and methods Whole-cell patch clamp recordings were...
Saved in:
Published in | Journal of electrocardiology Vol. 43; no. 5; pp. 440 - 448 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.09.2010
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Abstract The aim of this study was to determine the effects of desethyl-amiodarone (DEA), the major metabolite of the class III antiarrhythmic drug amiodarone, on human ether-à-go-go-related gene ( hERG ) encoded potassium channel current. Materials and methods Whole-cell patch clamp recordings were made at 37°C of ionic current ( I hERG ) carried by recombinant hERG channels expressed in HEK-293 cells. Results Desethyl-amiodarone inhibited I hERG with a half-maximal inhibitory concentration of approximately 158 nmol/L, compared with approximately 47 nmol/L for amiodarone. The inhibitory action of DEA on I hERG was contingent on channel gating, showing significant time and voltage dependence. Desethyl-amiodarone also produced an approximately −9 mV shift in the voltage dependence of activation of I hERG ; however, there was no significant preference for activated over inactivated channels. Conclusions Because hERG underlies native cardiac “ I Kr ” channels, hERG / I Kr inhibition by DEA as well as amiodarone may contribute to the overall effects of amiodarone administration on cardiac repolarization. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0022-0736 1532-8430 |
DOI: | 10.1016/j.jelectrocard.2010.04.007 |